A place to discuss science, share work, and find mentors and collaborators
Adaptive Phage Therapeutics has received $12 million from Deerfield Management and the AMR Action Fund as part of a new $24 million investment.
Adaptive Phage Therapeutics has received $12 million from Deerfield Management and the AMR Action Fund as part of a new $24 million investment.